D. Dalai

Statistics

Publications

Citations

547

H-Index

Active since

2019

Affiliations

Armauer Hansen Research Institute(Current)

University College London

Liverpool School of Tropical Medicine

Instituut voor Tropische Geneeskunde

University of the Witwatersrand

D. Dalai is an author at Armauer Hansen Research Institute specializing in tuberculosis care, drug-susceptible tuberculosis treatment, and tuberculosis pharmacotherapy.

Publications per year

2019–2022

Publications

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

Andrew Nunn, Patrick Phillips, Sarah Meredith et al. · New England Journal of Medicine · 2019 · 402 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 145 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +11

1–2 of 2